Pure Global AI
NCT06231264Recruiting

Transcutaneous Electrical Acustimulation in the Treatment of Mild to Moderate Ulcerative Colitis

A Multicenter Randomized Controlled Trial of Transcutaneous Electrical Acustimulation in the Treatment of Mild to Moderate Ulcerative Colitis
Xijing HospitalClinicalTrials.govdeviceDevice trial
Study focus
Disease/Condition
Ulcerative Colitis
Drug/Device/Intervention
transcutaneous electrical acustimulation at treatment sites
Study type
Interventional
Intervention type
device
Sponsor & location
Primary sponsor
Xijing Hospital
Location
Xi'an,Xi'an,Xi'an,Xi'an, China
Timeline & enrollment
Phase
N/A
Start date
Jan 19, 2024
End date
Mar 01, 2025
Enrollment
96 participants
Primary outcome

Clinical response

Summary

The aim of this study was to evaluate the efficacy and safety of transcutaneous electrical
 acustimulation in patients with mild to moderate ulcerative colitis.

ICD-10 classifications
Ulcerative colitisOther ulcerative colitisUlcerative colitis, unspecifiedArthropathy in ulcerative colitisJuvenile arthritis in ulcerative colitis
Data source
Registry
ClinicalTrials.gov
Trial ID
NCT06231264
Type
Device Trial
About this record

Access comprehensive clinical trial information for NCT06231264 through Pure Global AI's free database. This phase not specified trial is sponsored by Xijing Hospital and is currently Recruiting. The study focuses on Ulcerative Colitis. Target enrollment is 96 participants.

This page provides complete trial specifications, intervention details, outcomes, and location information. Pure Global AI offers free access to ClinicalTrials.gov data, helping medical device and pharmaceutical companies navigate clinical research efficiently.